ECSP992970A - SEQUENCE OF THE GENE RELATED TO ANGIOPOYETINO SCARFACE 3 - Google Patents
SEQUENCE OF THE GENE RELATED TO ANGIOPOYETINO SCARFACE 3Info
- Publication number
- ECSP992970A ECSP992970A ECSP992970A ECSP992970A EC SP992970 A ECSP992970 A EC SP992970A EC SP992970 A ECSP992970 A EC SP992970A EC SP992970 A ECSP992970 A EC SP992970A
- Authority
- EC
- Ecuador
- Prior art keywords
- scarface
- proteins
- angiopoyetino
- sequence
- gene related
- Prior art date
Links
Abstract
La invención proporciona compuestos de ácido nucleico, de scarface 3, sus proteínas y fragmentos aislados, estando dichas proteínas Scarface 3 relacionadas con la familia de la angiopoyetina. También se proporcionan vectores y células huésped heterólogas transformadas para expresar Scarface 3, procedimientos para la identificación de compuestos que se unen a, y/o modulan la actividad de, dichas proteínas Scarface 3, además de procedimientos para tratar cáncer y la mielosupresión, y composiciones farmacéuticas que comprenden Scarface 3 o sus análogos.The invention provides scarface 3 nucleic acid compounds, their proteins and isolated fragments, said Scarface 3 proteins being related to the angiopoietin family. Also provided are vectors and heterologous host cells transformed to express Scarface 3, procedures for the identification of compounds that bind to, and / or modulate the activity of, said Scarface 3 proteins, in addition to methods for treating cancer and myelosuppression, and compositions. Pharmaceuticals comprising Scarface 3 or its analogues.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP992970 ECSP992970A (en) | 1999-06-01 | 1999-06-01 | SEQUENCE OF THE GENE RELATED TO ANGIOPOYETINO SCARFACE 3 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ECSP992970 ECSP992970A (en) | 1999-06-01 | 1999-06-01 | SEQUENCE OF THE GENE RELATED TO ANGIOPOYETINO SCARFACE 3 |
Publications (1)
Publication Number | Publication Date |
---|---|
ECSP992970A true ECSP992970A (en) | 2000-01-27 |
Family
ID=42043959
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ECSP992970 ECSP992970A (en) | 1999-06-01 | 1999-06-01 | SEQUENCE OF THE GENE RELATED TO ANGIOPOYETINO SCARFACE 3 |
Country Status (1)
Country | Link |
---|---|
EC (1) | ECSP992970A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9695233B2 (en) | 2012-07-13 | 2017-07-04 | Roche Glycart Ag | Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases |
-
1999
- 1999-06-01 EC ECSP992970 patent/ECSP992970A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9695233B2 (en) | 2012-07-13 | 2017-07-04 | Roche Glycart Ag | Bispecific anti-VEGF/anti-ANG-2 antibodies and their use in the treatment of ocular vascular diseases |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR19C1020I1 (en) | NEW B7-4 MOLECULES AND THEIR USES | |
MX2020009514A (en) | Anti-claudin 18.2 antibodies. | |
BR112021012665A2 (en) | Useful polypeptides for gene editing and methods of use | |
BR112021022874A2 (en) | epcam binding proteins and methods of use | |
AR053063A2 (en) | SUBSTANTIALLY PURIFIED PROTEIN AND PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS IT | |
ES2096750T3 (en) | USEFUL RETROVIRIC VECTORS FOR GENIC THERAPY. | |
DK1005540T3 (en) | IKK-beta proteins, nucleic acids and methods | |
MX344216B (en) | Genetic products differentially expressed in tumors and the use thereof. | |
DK1103564T3 (en) | Cancer antigens based on the tumor suppressor gene WT1 product | |
ES2155702T4 (en) | HALTEROFORM EXPRESSIVE CONSTRUCTIONS FOR GENETIC THERAPY. | |
TR199902053T2 (en) | Compounds for immunotherapy of prostate cancer and methods for their use. | |
HK1092481A1 (en) | Polypeptides having binding affinity for her2 | |
BR9711795A (en) | Peptides having antiproliferative properties | |
NO20110429L (en) | Polypeptides and nucleic acid DNA for use in medicine | |
ATE211174T1 (en) | THYMIDINE KINASE MUTANTS | |
BR112022012327A2 (en) | ANTIBODIES OR FRAGMENTS THEREOF, NUCLEIC ACID, VECTOR AND HOST CELL | |
ATE300619T1 (en) | HUMAN CHECKPOINT KINASE, HCDS1, COMPOSITIONS AND METHODS | |
ATE473283T1 (en) | DNA EXPRESSION VECTORS | |
EP1012603A4 (en) | Functional fragments of hiv-1 vpr protein and methods of using the same | |
FR2744455B1 (en) | NOVEL NUCLEIC ACID SEQUENCES OF THE FAMILY OF TUMOR SUPPRESSOR FACTORS, CORRESPONDING EXPRESSION PRODUCTS AND THEIR APPLICATIONS | |
ECSP992970A (en) | SEQUENCE OF THE GENE RELATED TO ANGIOPOYETINO SCARFACE 3 | |
BR9712575A (en) | Process for restoring cells that have a mutated p53 protein, a p53-dependent transactivation activity, uses a single chain antibody capable of specifically binding a mutated p53 protein, and a coding nucleic acid, molecule 11d3 or a variant, nucleic acid and composition | |
EP0962530A3 (en) | Gene sequence encoding for the angiopoietin related protein scarface 1 | |
SE0301987D0 (en) | New polypeptide | |
SV1999000069A (en) | ANGIOPOYETIN RELATED TO SEQUENCE OF GEN 3 IN FACE SCAR REF. X-12261 |